News

The Centers for Medicare & Medicaid Services has launched a project to share claims data with accountable care organizations in bulk format, Administrator Seema Verma yesterday told participants at the Healthcare Information and Management Systems Society’s annual conference.

The AHA yesterday urged Sens. Bill Cassidy, R-La., and Dick Durbin, D-Ill., not to re-introduce legislation that would establish rehabilitation innovation centers as a new class of rehabilitation hospitals.

Senate Health, Education, Labor and Pensions Committee Chairman Lamar Alexander, R-Tenn., today convened a hearing on “Managing Pain During the Opioid Crisis” to “better understand causes of pain, how we can improve care for patients with pain, and where we are on developing new medicines and ways to treat pain.”

Committee Chairman Richard Neal, D-Mass., and Ranking Member Kevin Brady, R-Texas, said they are committed to working on bipartisan reforms to lower drug prices.

Hospitals and health systems are dedicated to safeguarding the privacy of patients’ medical information and believe that the current HIPAA rules are generally effective without greatly impeding the necessary exchange of information, AHA said.

The U.S. Preventive Services Task Force today recommended that clinicians provide or refer pregnant and postpartum women who are at increased risk for perinatal depression to counseling interventions.

The Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology and Centers for Medicare & Medicaid Services today proposed new rules to promote electronic health information exchange.

The AHA today expressed support for the Resident Physician Shortage Reduction Act, legislation that would add 15,000 Medicare-funded residency positions over five years to alleviate physician shortages that threaten patients' access to care.

In a commentary published Saturday in Modern Healthcare, AHA President and CEO Rick Pollack and Federation of American Hospitals President and CEO Chip Kahn illustrate why it’s so important for the nation to fully achieve the secure exchange of patient health data and highlight what it will take.

The Centers for Medicare & Medicaid Services will host a Feb. 14 call for clinicians and other interested stakeholders on new opioid policies for Medicare Part D plans that took effect Jan. 1.

In recent years, Airbnb, Uber and Netflix have changed the way we vacation, hail a ride and watch movies.

Reps.

Members of the pharmaceutical distribution supply chain, including dispensers such as hospitals and pharmacies, can apply through March 11 to participate in a Food and Drug Administration pilot program.

The Centers for Medicare & Medicaid Services will host a Feb. 14 call for clinicians and other interested stakeholders on new opioid policies for Medicare Part D plans that took effect Jan. 1.

Gov. Gina Raimondo this week signed an executive order establishing a 3.2 percent target for health care spending growth in Rhode Island through 2022.

The National Collaborative for Improving the Clinical Learning Environment has released two new resources.

The last thing a patient should worry about in a health crisis is an unanticipated medical bill that unintentionally impacts their out-of-pocket costs … and undermines the trust and confidence that patients have in their caregivers.

The AHA, Federation of American Hospitals, and American Society of Health-System Pharmacists today convened a panel of experts on Capitol Hill to discuss how continued rising drug prices, as well as shortages for many critical medications, are disrupting patient care and forcing hospitals to delay infrastructure and staffing investments and identify alternative therapies.

The Food and Drug Administration yesterday updated health care providers about a type of lymphoma

The U.S. District Court for the Western District of Pennsylvania has entered a consent decree prohibiting Ranier’s Rx Laboratory Inc. from manufacturing or distributing compounded drugs until they comply with the Federal Food, Drug, and Cosmetic Act and Food and Drug Administration regulations.